English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Insilico Medicine partners with Qilu Pharmaceutical for AI-driven cardiometabolic drug development
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

HHCM awards grants supporting psychedelic therapies for end-of-life care
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Singmed showcases new platforms for large-molecule drug delivery at Pharmapack Europe 2026
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

American Lung Association warns federal cuts threaten progress on tobacco control
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Leaders urged to prioritize subtraction of old tasks for successful goal execution
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Lilly partners with Seamless Therapeutics on $1.12B+ gene editing deal for hearing loss
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Roche reports positive results in obesity drug trial; Moderna halts vaccine studies

Trending
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones